Fierce Pharma1h
Fierce Pharma Asia—Takeda's oncology focus; Sun's Checkpoint buy; Ono-Ionis antisense deal
Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...
M&T Bank Corp Cuts Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
M&T Bank Corp lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 10.0% in the 4th ...
Fierce Biotech22h
‘I don't feel we lost momentum’: Takeda’s oncology execs sharpen focus after restructuring
Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...
Takeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit Headwinds
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Global Obizur Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends
The Business Research Company The Business Research Company's Obizur Global Market Report 2025 – Market Size, Trends, And Global Forecast 2 ...
Mass. man gets prison time for defrauding Takeda Pharmaceutical Co. of $2.3M
A Massachusetts man who, along with his girlfriend, defrauded Takeda Pharmaceutical Co. of $2.3 million and used the money to ...
American Association of Individual Investors3d
Which Is a Better Investment, Recursion Pharmaceuticals, Inc. or Veracyte, Inc. Stock?
Learn more about whether Recursion Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...
ABC63d
Brockton man sentenced for spending defrauded money on Mercedes, Boston Seaport condo
A Brockton man was sentenced for defrauding a pharmaceutical company out of $2.3 million and spending the proceeds on a ...